#,ama,title,journal,year,volume,issue,pages,doi,pmid,authors
1,"Pastis NJ, Simkovich S, Silvestri GA. Understanding the economic impact of introducing a new procedure: calculating downstream revenue of endobronchial ultrasound with transbronchial needle aspiration as a model. Chest. 2012;141(2).",Understanding the economic impact of introducing a new procedure: calculating downstream revenue of endobronchial ultrasound with transbronchial needle aspiration as a model,Chest,2012,141,2,,,,Pastis NJ; Simkovich S; Silvestri GA
2,"Mahajan AK, Bautista J, Hodson E. Financial justification for interventional pulmonology programs: terminology and programmatic models. Chest. 2020;158(3).",Financial justification for interventional pulmonology programs: terminology and programmatic models,Chest,2020,158,3,,,,Mahajan AK; Bautista J; Hodson E
3,"Van Dijk M, Sue R, Criner GJ. Expert statement: pneumothorax associated with one-way valve therapy for emphysema: 2020 update. Respiration. 2021;100(10).",Expert statement: pneumothorax associated with one-way valve therapy for emphysema: 2020 update,Respiration,2021,100,10,,,,Van Dijk M; Sue R; Criner GJ
4,"Israel B, Health L. None. None. 2022;None.",,,2022,,,,,,Israel B; Health L
5,"Criner GJ, Sue R, Wright S. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198(9).",A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE),Am J Respir Crit Care Med,2018,198,9,,,,Criner GJ; Sue R; Wright S
6,"Criner GJ, Delage A, Voelker K. Improving lung function in severe heterogenous emphysema with the Spiration Valve System (EMPROVE). A multicenter, open-label randomized controlled clinical trial. Am J Respir Crit Care Med. 2019;200(11).","Improving lung function in severe heterogenous emphysema with the Spiration Valve System (EMPROVE). A multicenter, open-label randomized controlled clinical trial",Am J Respir Crit Care Med,2019,200,11,,,,Criner GJ; Delage A; Voelker K
7,"Hopkinson NS, Kemp SV, Toma TP. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37(6).",Atelectasis and survival after bronchoscopic lung volume reduction for COPD,Eur Respir J,2011,37,6,,,,Hopkinson NS; Kemp SV; Toma TP
8,"Gompelmann D, Benjamin N, Bischoff E. Survival after endoscopic valve therapy in patients with severe emphysema. Respiration. 2019;97(2).",Survival after endoscopic valve therapy in patients with severe emphysema,Respiration,2019,97,2,,,,Gompelmann D; Benjamin N; Bischoff E
9,"Hartman JE, Welling J, Klooster K, Carpaij OA, Augustijn S, Slebos D. Survival in COPD patients treated with bronchoscopic lung volume reduction. Respir Med. 2022;196:106825.",Survival in COPD patients treated with bronchoscopic lung volume reduction,Respir Med,2022,196,,106825,,,Hartman JE; Welling J; Klooster K; Carpaij OA; Augustijn S; Slebos D
10,"Roodenburg SA, Slebos D, Van Dijk M, Koster TD, Klooster K, Hartman JE. Improved exercise capacity results in a survival benefit after endobronchial valve treatment. Respir Med. 2023;210:107175.",Improved exercise capacity results in a survival benefit after endobronchial valve treatment,Respir Med,2023,210,,107175,,,Roodenburg SA; Slebos D; Van Dijk M; Koster TD; Klooster K; Hartman JE
11,"Low S, Lee JZ, Desai H, Hsu C, Sam AR, Knepler JL. Endobronchial valves therapy for advanced emphysema: a metaanalysis of randomized trials. J Bronchol Interv Pulmonol. 2019;26(2).",Endobronchial valves therapy for advanced emphysema: a metaanalysis of randomized trials,J Bronchol Interv Pulmonol,2019,26,2,,,,Low S; Lee JZ; Desai H; Hsu C; Sam AR; Knepler JL
12,"Patel M, Chowdhury J, Zhao H. Meta-analysis and systematic review of bronchoscopic lung volume reduction through endobronchial valves in severe emphysema. J Bronchol Interv Pulmonol. 2022;29(3).",Meta-analysis and systematic review of bronchoscopic lung volume reduction through endobronchial valves in severe emphysema,J Bronchol Interv Pulmonol,2022,29,3,,,,Patel M; Chowdhury J; Zhao H
13,"Kemp SV, Slebos DJ, Kirk A. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196(12).",A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM),Am J Respir Crit Care Med,2017,196,12,,,,Kemp SV; Slebos DJ; Kirk A
14,"Cerullo M, Chen SY, Dillhoff M, Schmidt C, Canner JK, Pawlik TM. Association of hospital market concentration with costs of complex hepatopancreaticobiliary surgery. JAMA Surg. 2017;152(9):172158.",Association of hospital market concentration with costs of complex hepatopancreaticobiliary surgery,JAMA Surg,2017,152,9,172158,,,Cerullo M; Chen SY; Dillhoff M; Schmidt C; Canner JK; Pawlik TM
15,"Haider AH, Obirieze A, Velopulos CG. Incremental cost of emergency versus elective surgery. Ann Surg. 2015;262(2).",Incremental cost of emergency versus elective surgery,Ann Surg,2015,262,2,,,,Haider AH; Obirieze A; Velopulos CG
16,"Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: How good a basis for estimating costs?. Inquiry. 1995;32(4).",The ratio of costs to charges: How good a basis for estimating costs?,Inquiry,1995,32,4,,,,Shwartz M; Young DW; Siegrist R
17,"Chen LM, Jha AK, Guterman S, Ridgway AB, Orav EJ, Epstein AM. Hospital cost of care, quality of care, and readmission rates: penny wise and pound foolish?. Arch Intern Med. 2010;170(4).","Hospital cost of care, quality of care, and readmission rates: penny wise and pound foolish?",Arch Intern Med,2010,170,4,,,,Chen LM; Jha AK; Guterman S; Ridgway AB; Orav EJ; Epstein AM
18,"Childers CP, Dworsky JQ, Russell MM, Maggard-Gibbons M. Comparison of cost center-specific vs hospital-wide cost-tocharge ratios for operating room services at various hospital types. JAMA Surg. 2019;154(6).",Comparison of cost center-specific vs hospital-wide cost-tocharge ratios for operating room services at various hospital types,JAMA Surg,2019,154,6,,,,Childers CP; Dworsky JQ; Russell MM; Maggard-Gibbons M
19,"Desai NR, French KD, Diamond EJ, Kovitz KL. Value-based proposition for a dedicated interventional pulmonology suite: an adaptable business model. Chest. 2018;154(3).",Value-based proposition for a dedicated interventional pulmonology suite: an adaptable business model,Chest,2018,154,3,,,,Desai NR; French KD; Diamond EJ; Kovitz KL
